Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ambea ABCHIX:AMBEAS 79 3-Year Book Growth Rate is 7.10% as of Jun. 2026, which is 25% below its 10-year median of 9.50. GuruFocus rates CHIX:AMBEAS with a GF Score™ of 79/100 and a GF Value™ of kr115.23. The stock has 9 warning signs investors should review. Among 581 Healthcare Providers & Services companies, Ambea AB ranks better than 55.25% on this metric.
During the past 12 months, Ambea AB's average Book Value per Share Growth Rate was 7.30% per year.
During the past 3 years, the average Book Value per Share Growth Rate was 7.10% per year.
During the past 5 years, the average Book Value per Share Growth Rate was 6.90% per year.
During the past 10 years, the average Book Value per Share Growth Rate was 9.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
During the past 10 years, the highest 3-Year average Book Value per Share Growth Rate of Ambea AB was 15.70% per year. The lowest was 6.20% per year. And the median was 9.50% per year.
Ambea AB (CHIX:AMBEAs) 3-Year Book Growth Rate Explanation
Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.
Ambea AB 3-Year Book Growth Rate Related Terms
CHIX:AMBEAS vs HCA, THC, EHC: 3-Year Book Growth Rate Comparison
For the Medical Care Facilities subindustry, Ambea AB's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ambea AB 3-Year Book Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Ambea AB's 3-Year Book Growth Rate distribution charts can be found below:
* The bar in red indicates where Ambea AB's 3-Year Book Growth Rate falls into.
This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.
What does a 3-Year Book Growth Rate of 7.10% mean?
Ambea AB (CHIX:AMBEAS) has a 3-Year Book Growth Rate of 7.10% as of Jun. 2026. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Ambea AB and its competitors. This is 25% below median its historical median of 9.50. Over the past decade, Ambea AB's 3-Year Book Growth Rate has ranged from 6.20 to 15.70. According to the industry distribution chart, Ambea AB ranks #260 out of 581 companies in the Healthcare Providers & Services industry, placing it in the top 44.8%.
Is Ambea AB's 3-Year Book Growth Rate too high?
Ambea AB's current 3-Year Book Growth Rate of 7.10% is 25% below median its 10-year median of 9.50. Over the past 10 years, this metric has ranged from a low of 6.20 to a high of 15.70. The Healthcare Providers & Services industry median 3-Year Book Growth Rate is 5.40. Ambea AB's value of 7.10% is 31.5% above this industry median. Based on the distribution chart, Ambea AB ranks #260 out of 581 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Ambea AB has a GF Score™ of 79/100, reflecting its overall financial health beyond just this single metric.
How does Ambea AB's 3-Year Book Growth Rate compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Ambea AB ranks #260 out of 581 companies for 3-Year Book Growth Rate. This puts Ambea AB in the upper half of its industry. The industry median 3-Year Book Growth Rate is 5.40. Ambea AB's value of 7.10% is 31.5% above this benchmark. Historically, Ambea AB's own 3-Year Book Growth Rate has ranged from 6.20 to 15.70 over the past decade. While the company's 10-year median is 9.50 vs. the industry median of 5.40, Ambea AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Book Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Book Growth Rate among Healthcare Providers & Services companies is 5.40, based on 581 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Book Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Book Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ambea AB's current 3-Year Book Growth Rate of 7.10% is 31.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Book Growth Rate mean?
A high 3-Year Book Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Book Growth Rate is the 3-year average growth rate of Book Value per Share. View historical data for Ambea AB and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Book Growth Rate is 5.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ambea AB's current 3-Year Book Growth Rate is 7.10%, which is 25% below median its own 10-year median of 9.50. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ambea AB stock overvalued right now?
Ambea AB (CHIX:AMBEAS) has a current 3-Year Book Growth Rate of 7.10%. The stock's GF Value™ is kr115.23, compared to a current price of kr144.20 — trading 25.1% above its estimated fair value. The current 3-Year Book Growth Rate is 7.10%, which is 25% below median its 10-year median of 9.50 and 31.5% above the Healthcare Providers & Services industry median of 5.40. Ambea AB's overall GF Score™ is 79/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Book Growth Rate calculated?
3-Year Book Growth Rate is calculated from a company's financial statements. For Ambea AB (CHIX:AMBEAS), the current 3-Year Book Growth Rate is 7.10% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ambea AB (CHIX:AMBEAS) Overvalued in 2026?
Based on GuruFocus' analysis, Ambea AB stock appears to be overvalued.
The current stock price of kr144.20 is trading 25.1% above its estimated GF Value™ of kr115.23.
Key valuation signals for CHIX:AMBEAS:
3-Year Book Growth Rate: 7.10% (25% below median its 10-year median of 9.50)
GF Value™: kr115.23 vs. price of kr144.20 (25.1% above fair value)
Industry Position: 31.5% above the Healthcare Providers & Services median (#260 of 581)
No single metric tells the full story. See the CHIX:AMBEAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ambea AB is a Swedish care provider operating across Sweden, Norway, and Denmark. The company delivers elderly care, disability care, psychosocial support, and individual and family care, largely on behalf of municipalities and public authorities. Its operations are organised into several business areas: Vardaga provides nursing homes and home care in Sweden; Nytida offers social care and support for children, young people, and adults in Sweden; Stendi delivers social care services in Norway; Altiden operates social care and elderly care in Denmark; and Klara supplies competence and staffing solutions, including student health services, in Sweden. Revenue comes primarily from publicly funded care contracts and staffing services, with Vardaga representing the largest share. Ambea is listed on Nasdaq Stockholm and is one of the Nordic region's larger private care operators.
79GF Score
Get the complete analysis for CHIX:AMBEAS
3-Year Book Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:AMBEAS has been successfully added to your 
